92%Confidence
0Views
FDASource
2026-03-02Date
Summary
Asteria Health's second testosterone pellet recall for metal contamination suggests widespread manufacturing problems affecting multiple product strengths. This pattern indicates systemic contamination issues that may require facility shutdowns or comprehensive remediation efforts.
Actionable: Consider Asteria Health as high-risk for business disruption and potential regulatory sanctions given repeated contamination events.
AI Confidence: 92%
Data Points
firmF.H. INVESTMENTS, Inc. (dba Asteria Health)
classificationClass II
statusOngoing
distributionNationwide in the USA
productTestosterone, 200 mg, 1 Sterile Pellet, Asteria Health 432 Industrial Ln, Birmingham, AL 35211, NDC: 79559-1200-43.
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now